文献速递临床试验与 GCP真实世界研究与卫生经济

基于依恋的家庭治疗对高自杀意念年轻成人的有效性与成本效益:一项随机对照试验方案

The effectiveness and cost-effectiveness of attachment-based family therapy for young adults with high suicidal ideation: protocol of a randomized controlled trial.
PubMed 文献 · Trials · 2024-10-16

本研究为荷兰与比利时的实用性多中心随机对照试验,纳入142名16至30岁、自杀意念问卷青少年版(SIQ-JR)评分≥31的高自杀意念年轻成人及其照护者,比较基于依恋的家庭治疗(ABFT)与常规治疗(TAU)对自杀意念的有效性与成本效益,主要结局为SIQ-JR,随访至干预后12个月。

要点

  • ABFT为16周以依恋与情绪为重点的治疗,已在多个欧洲国家精神卫生机构实施。
  • 研究纳入SIQ-JR评分≥31的16至30岁年轻成人142名及其照护者,比较ABFT与TAU。
  • 主要结局为自杀意念(SIQ-JR),评估时点为基线、干预后(基线后5个月)及干预后3、6、12个月。

核心结论

  • 研究旨在评估ABFT相较TAU对自杀意念的有效性与成本效益,作者预测ABFT在所有时点较TAU带来更强的自杀意念下降且更具成本效益。
  • 作者还预期ABFT组抑郁症状下降更强,家庭功能、自主性、困陷感及年轻成人依恋改善更明显。

研究设计与样本

  • 实用性多中心随机对照试验,在荷兰与比利时13个参与站点开展,纳入142名16至30岁、SIQ-JR评分≥31的寻求精神卫生治疗的年轻成人及其照护者。
  • 对照为常规治疗(TAU),ABFT为16周以依恋与情绪为重点的治疗。
  • 主要结局为自杀意念(SIQ-JR),评估时点为基线、干预后(基线后5个月)及干预后3、6、12个月。
  • 试验已在ClinicalTrials.gov注册(NCT05965622,首次发布2023年7月28日)。

局限性

  • 原文指出,当前指南推荐用于高致命性自杀风险青少年的心理与药物治疗效果有限。
  • 原文指出,ABFT在新兴成人中的(成本)效果尚未被研究。
  • 原文指出,自杀新兴成人的治疗研究不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Young adult suicidality is worldwide a prevalent mental health problem and the number one cause of death, with devastating consequences for individuals and their families, and substantial economic costs. However, psychological and pharmacological treatments currently recommended in guidelines for treatment of high-risk youth for fatal suicide have limited effect. In line with the World Health Organization's (WHO) recommendation to involve the family in treatment of these youth, attachment-based family therapy (ABFT) was developed, a 16-week attachment and emotion-focused treatment, implemented in mental health care settings across various European countries in the past years, and becoming increasingly popular among therapists. However, the (cost-)effectiveness of ABFT has not been studied in emerging adults. In the proposed pragmatic randomized controlled trial (RCT), we aim to evaluate the effectiveness and cost-effectiveness of ABFT compared to treatment as usual (TAU) on suicidality, as delivered in daily practice. METHODS: This pragmatic multicenter study in the Netherlands and Belgium includes 13 participating sites. Participants are suicidal young adults (≥ 31 SIQ-JR score) between 16 and 30 years old who seek mental health treatment (n = 142) and their caregivers. The primary outcome is suicidality (SIQ-JR), with assessments at baseline, post-intervention (5 months after baseline), 3, 6, and 12 months after intervention. We predict that, compared to TAU, ABFT will lead to a stronger reduction in suicidality and will be more cost-effective, over the course of all time points. We also expect stronger decreases in depressive symptoms, given that suicidality is very common in individuals with depressive disorder, as well as more improvement in family functioning, autonomy, entrapment, and young adult attachment, in the ABFT condition. DISCUSSION: This study can contribute to improving the care for suicidal youngsters with high mortality risk. Treatment of suicidal emerging adults is understudied. The results will inform clinical guidelines and policy makers and improve treatment of suicidal emerging adults. TRIAL REGISTRATION: This trial is registered on ClinicalTrials.gov (NCT05965622, first posted on July 28, 2023).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Bockting C, Bosmans G, Bergers N, et al. The effectiveness and cost-effectiveness of attachment-based family therapy for young adults with high suicidal ideation: protocol of a randomized controlled trial. Trials. 2024. PMID: 39415182. doi:10.1186/s13063-024-08499-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。